✦ LIBER ✦

The use of intermediate dose methotrexate in increased risk childhood acute lymphoblastic leukemia a comparison of three versus six courses

✍ Scribed by Daniel M. Green; Martin L. Brecher; Leslie E. Blumenson; Mauro Grossi; Arnold I. Freeman

Publisher: John Wiley and Sons
Year: 1982
Tongue: English
Weight: 523 KB
Volume: 50
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19821215)50:12<2722::aid-cncr2820501204>3.0.co;2-t

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomized comparison of moderate-dose m

Randomized comparison of moderate-dose methotrexate infusions to oral methotrexate in children with intermediate risk acute lymphoblastic leukemia: A Childrens Cancer Group study

✍ Lange, Beverly J.; Blatt, Julie; Sather, Harland N.; Meadows, Anna T. 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 559 KB

Methotrexate (MTX) infusions of 500-1,000 mg/m2 over 24 hours may improve survival and prevent relapse in children with acute lymphoblastic leukemia (ALL). Childrens Cancer Group (CCG) Study 139 compared weekly oral methotrexate 20 mg/m2/ week (oral MTX) to MTX 500 mg/m2 infused over 24 hours (IV MT

A randomized, postremission comparison o

A randomized, postremission comparison of four courses of standard-dose consolidation therapy without maintenance therapy versus three courses of standard-dose consolidation with maintenance therapy in adults with acute myeloid leukemia : The Japan Adult Leukemia Study Group AML97 study

✍ Shuichi Miyawaki; Hisashi Sakamaki; Shigeki Ohtake; Nobuhiko Emi; Fumiharu Yagas 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 316 KB 👁 1 views